# Commission Implementing Regulation (EU) 2019/336 of 27 February 2019 amending Regulation (EU) No 1141/2010 and Implementing Regulation (EU) No 686/2012 as regards the rapporteur Member State for the evaluation of 1-methylcyclopropene, famoxadone, mancozeb, methiocarb, methoxyfenozide, pirimicarb, pirimiphos-methyl and thiacloprid (Text with EEA relevance), Annex I

Extent: E+W+S+N.I.

Part A of the Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:
(a) the entry for 1-methyl-cyclopropene is replaced by the following:
Active substance
Rapporteur Member State
Co-rapporteur Member State
‘1-methyl-cyclopropene
NL’
(b) the entry for Mancozeb is replaced by the following:
Active substance
Rapporteur Member State
Co-rapporteur Member State
‘Mancozeb
EL’
(c) the entry for Methiocarb is replaced by the following:
Active substance
Rapporteur Member State
Co-rapporteur Member State
‘Methiocarb
DE’
(d) the entry for Methoxyfenozide is replaced by the following:
Active substance
Rapporteur Member State
Co-rapporteur Member State
‘Methoxyfenozide
SK’
(e) the entry for Pirimicarb is replaced by the following:
Active substance
Rapporteur Member State
Co-rapporteur Member State
‘Pirimicarb
SE’
(f) the entry for Pirimiphos-methyl is replaced by the following:
Active substance
Rapporteur Member State
Co-rapporteur Member State
‘Pirimiphos-methyl
FR’
(g) the entry for Thiacloprid is replaced by the following:
Active substance
Rapporteur Member State
Co-rapporteur Member State
‘Thiacloprid
DE’

---
Source: https://www.legislation.gov.uk/eur/2019/336/annex/I (the official version)
Page: https://openlegislation.uk/eu-regulation-2019-336/annex-I
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.